Search

Your search keyword '"Hansson, Markus"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Hansson, Markus" Remove constraint Author: "Hansson, Markus" Database OpenAIRE Remove constraint Database: OpenAIRE
40 results on '"Hansson, Markus"'

Search Results

1. Preliminary Dose-Escalation Results from a Phase 1/2 Study of GEN3014 (HexaBody (R)-CD38) in Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM)

2. Additional file 1 of Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission ��� results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial

3. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

4. Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016

6. Carfilzomib and dexamethasone maintenance prolong time to progression following salvage ASCT in multiple myeloma: A randomized phase 2 trial by the nordic myeloma study group

8. Additional file 1: of Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis

9. Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes

10. Additional file 3: of Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis

11. Additional file 2: of Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis

12. Additional file 5: of Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis

13. Additional file 4: of Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis

14. Additional file 2: of Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9

15. Additional file 1: of Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes

16. Health-related quality of life in multiple myeloma patients with first relapse treated with Carfilzomib-based re-induction and salvage autologous stem cell transplantation:data from a Nordic phase II trial

17. Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology

18. Carfilzomib-Cyclophosphamide-Dexamethasone induction and salvage ASCT transplant-eligible multiple myeloma with firs trelapse after upfront ASCT

19. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

20. Tracking and Serving Geolocated Ads, Load Balancing, and Scaling of Server Resources

21. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

22. Quality of life with melphalan/prednisone plus either thalidomide (MPT-T) or lenalidomide (MPR-R) in non-transplant eligible newly diagnosed multiple myeloma:results of the HOVON87/NMSG18 study

23. Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Initial Results from the Randomized Phase II HOVON-126/Nmsg 21.13 Trial

28. An Updated Analysis of the Stratus Trial (MM-010): Safety and Efficacy of Pomalidomide Plus Low-Dose Dexamethasone (POM plus LoDEX) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

31. Outcomes for Older Patients in Stratus (MM-010), a Single-Arm, and Phase 3b Study of Pomalidomide plus Low-Dose Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma

32. Ledarskapsskillnader mellan ofentligt och privat anställda ledare : När sektorstillhörighet inte längre är relevant

33. Avhopp inom föreningsidrotten- varför tonårsflickor väljer att sluta föreningsidrotta

34. Hastighetskameror – ett brottsförebyggande och normskapande styrmedel? : enkätundersökning kring hastighetskameror

35. Låneförbudet i ABL

36. Låneförbudet i ABL

38. Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9

39. Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9

40. Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9

Catalog

Books, media, physical & digital resources